Dimensional Fund Advisors’s DiaMedica Therapeutics DMAC Stock Holding History

Dimensional Fund Advisors’s Portfolio DMAC Stock Details DMAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19,339	Closed	-$75.4K	–	3291
2025 Q2	$75.4K	Hold	19,339	–	–	﹤0.01%	3208
2025 Q1	$73.3K	Hold	19,339	–	–	﹤0.01%	3234
2024 Q4	$105K	Buy	19,339 +2,380	+14%	+$11.2K	﹤0.01%	3237
2024 Q3	$71.1K	Hold	16,959	–	–	﹤0.01%	3267
2024 Q2	$50K	Hold	16,959	–	–	﹤0.01%	3317
2024 Q1	$47K	Hold	16,959	–	–	﹤0.01%	3335
2023 Q4	$48.2K	Hold	16,959	–	–	﹤0.01%	3350
2023 Q3	$43.8K	Hold	16,959	–	–	﹤0.01%	3391
2023 Q2	$73.3K	Hold	16,959	–	–	﹤0.01%	3368
2023 Q1	$25.9K	Sell	16,959 -25,675	-60%	-$40.7K	﹤0.01%	3426
2022 Q4	$68	Hold	42,634	–	–	﹤0.01%	3367
2022 Q3	$53K	Sell	42,634 -15,381	-27%	-$24K	﹤0.01%	3399
2022 Q2	$117K	Hold	58,015	–	–	﹤0.01%	3313
2022 Q1	$145K	Buy	58,015 +46,115	+388%	+$131K	﹤0.01%	3351
2021 Q4	$44K	Buy	+11,900	New	+$46.7K	﹤0.01%	3500
2021 Q3	–	Sell	-14,074	Closed	-$63K	–	3508
2021 Q2	$63K	Buy	+14,074	New	+$115K	﹤0.01%	3431

Other funds holding DMAC

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Dimensional Fund Advisors's DMAC Position: Q3 2025 in Review

Dimensional Fund Advisors sold out of DiaMedica Therapeutics (DMAC) in Q3 2025, closing a stake of 19,339 shares — an estimated $75.4K sold.

Dimensional Fund Advisors first reported a position in DMAC in Q2 2021 and held it in 16 quarters. The position peaked at $145K in Q1 2022. 78 funds tracked by Wall St. Rank hold DMAC as of Q3 2025.

Dimensional Fund Advisors reported no remaining DiaMedica Therapeutics position as of Q3 2025 after selling out during the quarter.
Dimensional Fund Advisors sold 19,339 DiaMedica Therapeutics shares in Q3 2025, an estimated $75.4K.
Dimensional Fund Advisors first reported a position in DiaMedica Therapeutics in Q2 2021 and held it in 16 quarters.
Dimensional Fund Advisors's DiaMedica Therapeutics position peaked at $145K in Q1 2022.
78 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q3 2025.

Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.